Maxair and Pataday drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Maxair (pirbuterol acetate) and Pataday (olopatadine hydrochloride). Common drug interactions include palpitations among females and hypoxia among males.

The phase IV clinical study analyzes what interactions people have when they take Maxair and Pataday. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Maxair?

Maxair has active ingredients of pirbuterol acetate. It is often used in asthma. eHealthMe is studying from 2,903 Maxair users. Check the latest studies of Maxair.

What is Pataday?

Pataday has active ingredients of olopatadine hydrochloride. It is often used in allergies. eHealthMe is studying from 8,288 Pataday users. Check the latest studies of Pataday.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

11 people who take Maxair and Pataday together, and have interactions are studied.

What are the common drug interactions of Maxair and Pataday, by gender? *:

female:

Palpitations (feelings or sensations that your heart is pounding or racing)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Pleuritic pain
Rhinorrhoea (watery mucus discharge from the nose)
Tinnitus (a ringing in the ears)
Abdominal pain
Ageusia (loss of taste functions of the tongue)
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Anaemia (lack of blood)
Anxiety

male:

Hypoxia (low oxygen in tissues)
Pyrexia (fever)

What are the common drug interactions of Maxair and Pataday, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Hypoxia (low oxygen in tissues)
Pyrexia (fever)

20-29:

n/a

30-39:

Abdominal pain
Ageusia (loss of taste functions of the tongue)
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Anaemia (lack of blood)
Anxiety
Arthralgia (joint pain)
Balance disorder
Body temperature increased
Bone marrow failure
Breast cancer

40-49:

n/a

50-59:

Anaphylactic reaction (serious allergic reaction)

60+:

Cardiac disorder
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Cough
Dysphonia (speech disorder attributable to a disorder of phonation)
Oedema peripheral (superficial swelling)
Oropharyngeal pain
Pain
Pleuritic pain
Retinal vascular thrombosis (clot formation in small veins that carry blood away from the retina)

What are the existing conditions these people have? *

Allergic Rhinitis: 4 people, 36.36%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 27.27%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 9.09%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 9.09%
Anaemia (lack of blood): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Maxair and Pataday?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously